Evidence map›Paper›PMID 35424586›Full record

ArticleRSC advances2022

Functionalized quinolizinium-based fluorescent reagents for modification of cysteine-containing peptides and proteins.

Karen Ka-Yan Kung, Cai-Fung Xu, Wa-Yi O, Qiong Yu, Sai-Fung Chung, Suet-Ying Tam, Yun-Chung Leung, Man-Kin Wong

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Karen Ka-Yan KungThe Hong Kong Polytechnic University Shenzhen Research Institute Shenzhen 518057 China mankin.wong@polyu.edu.hk.ORCID https://orcid.org/0000-0002-2732-4369
Cai-Fung XuThe Hong Kong Polytechnic University Shenzhen Research Institute Shenzhen 518057 China mankin.wong@polyu.edu.hk.
Wa-Yi OThe Hong Kong Polytechnic University Shenzhen Research Institute Shenzhen 518057 China mankin.wong@polyu.edu.hk.
Qiong YuThe Hong Kong Polytechnic University Shenzhen Research Institute Shenzhen 518057 China mankin.wong@polyu.edu.hk.
Sai-Fung ChungHenry Cheng Research Laboratory for Drug Development, Lo Ka Chung Centre for Natural Anti-Cancer Drug Development, The Hong Kong Polytechnic University Hung Hom Hong Kong China thomas.yun-chung.leung@polyu.edu.hk.
Suet-Ying TamHenry Cheng Research Laboratory for Drug Development, Lo Ka Chung Centre for Natural Anti-Cancer Drug Development, The Hong Kong Polytechnic University Hung Hom Hong Kong China thomas.yun-chung.leung@polyu.edu.hk.
Yun-Chung LeungHenry Cheng Research Laboratory for Drug Development, Lo Ka Chung Centre for Natural Anti-Cancer Drug Development, The Hong Kong Polytechnic University Hung Hom Hong Kong China thomas.yun-chung.leung@polyu.edu.hk.
Man-Kin WongThe Hong Kong Polytechnic University Shenzhen Research Institute Shenzhen 518057 China mankin.wong@polyu.edu.hk.ORCID https://orcid.org/0000-0003-1574-6860
Hong Kong Polytechnic University · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of quinolizinium-based fluorescent reagents were prepared by visible light-mediated gold-catalyzed

Identifiers

PMID35424586
PMCPMC8981741
OpenAlexW4212866414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.